Napa Valley’s V Foundation Wine Celebration honored cancer patients, researchers and the enduring legacy of Jim Valvano.

BioMarin said the FDA accepted a supplemental filing to convert VOXZOGO from accelerated to full approval for children with achondroplasia; PDUFA date is Feb. 28, 2027.

A Napa nonprofit's internship pipeline helped build a prototype Virtual Neurologist AR headset that organizers say could speed stroke diagnosis and is heading toward ambulance pilots.